We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Families Say Animal Studies Back Their Claims In Zofran MDL

Law360, New York (January 6, 2016, 3:38 PM EST) -- Families who claim that GlaxoSmithKline’s “off label” promotion of its anti-nausea drug Zofran for morning sickness led to birth defects urged the Massachusetts federal judge overseeing the multidistrict litigation on Wednesday not to dismiss their claims, pointing to animal studies they say support their allegations.

The families told U.S. District Judge F. Dennis Saylor IV that GlaxoSmithKline LLC’s motion to dismiss all of their more than 200 cases is premature, as no discovery has yet been undertaken, and since the U.S. Food and Drug Administration hasn’t...
To view the full article, register now.




Case Information

Case Title

In Re: Zofran (Ondansetron)Products Liability Litigation

Case Number




Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability


F. Dennis Saylor, IV

Date Filed

October 13, 2015

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.